Parmax Pharma Limited Share Price
Parmax Pharma Limited Share Price Today
As of 25 Jul 2026, Parmax Pharma Limited share price is ₹102.83. The stock opened at ₹102.83, compared to its previous close of ₹104.92. During today's trading session, Parmax Pharma Limited share price moved in the range of ₹102.83 to ₹102.83, with an average price of ₹102.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹22.60 and a high of ₹109.20.
Parmax Pharma Limited Returns Calculator
Parmax Pharma Limited Shareholder Returns
Parmax Pharma Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,65,711.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,93,860.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,92,687.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,12,593.00 | 33.55 | 3.27 | 11.27% | 0.00 | 14.95% | 423.36 | 0.93% | 0.44 | 43.52 |
| Zydus Lifesciences | 1,11,082.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,553.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,607.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 97,364.90 | 30.58 | 2.56 | 11.07% | 0.18 | 12.54% | 377.96 | 0.69% | 0.41 | 38.68 |
| Aurobindo Pharma | 88,508.40 | 25.27 | 2.34 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 84,727.30 | 60.26 | 10.10 | 18.21% | 0.40 | 16.70% | 97.21 | 0.12% | 0.64 | 13.72 |
Parmax Pharma Limited Financials
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹28.20 | ₹11.05 | ₹15.42 | ₹18.25 |
| Other Income | ₹0.04 | ₹0.05 | ₹0.04 | ₹0.06 |
| Total Revenue | ₹28.24 | ₹11.10 | ₹15.46 | ₹18.31 |
| Total Expenses | ₹29.57 | ₹16.76 | ₹15.42 | ₹18.01 |
| Profit Before Tax | -₹2.40 | -₹5.66 | ₹0.05 | ₹0.30 |
| Tax | -₹0.30 | ₹0.09 | ₹0.15 | ₹0.16 |
| Profit After Tax | -₹2.09 | -₹5.75 | -₹0.10 | ₹0.14 |
| EPS - Basic | -₹5.60 | -₹34.56 | -₹0.28 | ₹0.38 |
| EPS - Diluted | -₹5.60 | -₹34.56 | -₹0.28 | ₹0.38 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹2.40 | -₹5.66 | ₹0.05 | ₹0.30 |
| Income before WC changes | -₹0.59 | -₹4.07 | ₹1.74 | ₹2.02 |
| Change in Assets | -₹4.19 | ₹1.80 | -₹1.23 | ₹2.66 |
| Change in Liabilities | ₹3.83 | ₹2.08 | -₹0.18 | -₹3.93 |
| Change in WC | -₹0.36 | ₹3.88 | -₹1.41 | -₹1.27 |
| Cash flow from Operations | -₹0.96 | -₹0.20 | ₹0.33 | ₹0.75 |
| Cash flow from Investing | -₹0.70 | -₹1.59 | -₹0.94 | -₹1.53 |
| Cash flow from Financing | ₹1.40 | ₹1.43 | -₹0.04 | -₹0.91 |
| Total Cash Flow | -₹0.26 | -₹0.36 | -₹0.65 | -₹1.69 |
| Cash (Start of the year) | ₹0.05 | ₹0.41 | ₹1.05 | ₹2.75 |
| Cash (End of the year) | -₹0.21 | ₹0.05 | ₹0.41 | ₹1.05 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹8.75 | ₹9.56 | ₹10.08 | ₹11.42 |
| Current Assets | ₹10.00 | ₹5.77 | ₹7.53 | ₹6.56 |
| Total Assets | ₹18.75 | ₹15.33 | ₹17.61 | ₹17.97 |
| Current Liabilities | ₹13.04 | ₹9.21 | ₹7.14 | ₹7.31 |
| Net Current Asset | -₹3.03 | -₹3.44 | ₹0.39 | -₹0.75 |
| Non-Current Liabilities | ₹7.70 | ₹6.01 | ₹4.62 | ₹4.70 |
| Equity Capital | -₹1.99 | ₹0.11 | ₹5.86 | ₹5.96 |
| Total Equity & Liabilities | ₹18.75 | ₹15.33 | ₹17.61 | ₹17.97 |
About Parmax Pharma Limited
Parmax Pharma Ltd is an India-based company, which is engaged in active pharmaceutical ingredients (API) and contract manufacturing operations (CMO) business. It uses quality by design techniques to produce complex molecules enabling customers to create formulations. The Company’s manufacturing units run in accordance with current good manufacturing practices (cGMP). Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Ormeloxifene Hydrochloride I.P., Milnacipram HCl, Calciumpoly Carbophil usp, Levosulpride, Paliperidone, Edaravone, Lacosamide, Iloperidone, Prasugrel HCl, 2-Acetyl Thiophene, Morpholine Hydrochloride, Camphor Sulfonyl Chloride, ISB-I (2-Chlorobenzaldehyde-5-Sulfonic acid disodium salt), Benzaldehyde-2, 5-Di-Sulfonic acid disodium salt, 2-picolinoxylidide, 4-Octyl amino pyridine (4-OAP), Sitagliptin phosphate Monohydrate API, Solifenacin Succinate API, Vilazodone Hydrochloride API, and Azelnidipine API.
Parmax Pharma Limited Financial Highlights
- Revenue: Parmax Pharma Limited reported revenue of ₹12.16 crore in FY26 vs ₹28.24 crore in FY25. It showed a decrease of 56.94% on a yearly basis.
- Operating Profit: Parmax Pharma Limited reported an operating loss of ₹5.85 crore in FY26 vs ₹2.40 crore in FY25. It showed a decrease of 143.75% on a year-on-year basis.
- Net Profit: Parmax Pharma Limited reported a net loss of ₹4.16 crore in FY26 vs ₹2.09 crore in FY25. It showed a decrease of 99.04% on a yearly basis.
Parmax Pharma Limited Quarterly Result Highlights
- Parmax Pharma Limited reported revenue of ₹3.34 crore in Mar 2026, compared with ₹4.34 crore in Dec 2025, representing a decrease of 23.04% on a quarter-on-quarter (QoQ) basis.
- Parmax Pharma Limited reported an operating loss of ₹2.27 crore in Mar 2026, compared with ₹0.73 crore in Dec 2025, representing a decrease of 210.96% on a quarter-on-quarter (QoQ) basis.
- Parmax Pharma Limited reported a loss of ₹0.58 crore in Mar 2026, compared with ₹0.73 crore in Dec 2025, reflecting an increase of 20.55% on a QoQ basis.
- The earnings per share (EPS) of Parmax Pharma Limited stood at ₹5.60 during Mar 2026.
Similar Stocks
FAQs on Parmax Pharma Limited Share Price
What is Parmax Pharma Limited share price today?
Parmax Pharma Limited share price is ₹102.83 as on 24 Jul, 2026, 14:15 IST.
How has the Parmax Pharma Limited share price performed in the past?
In the last 1 year, Parmax Pharma Limited delivered a return of 160.40%. The Parmax Pharma Limited share price hit a high of ₹109.20 and low of ₹22.60.
How much is the Mutual Fund shareholding in Parmax Pharma Limited shares?
The Mutual Fund Shareholding in Parmax Pharma Limited was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of Parmax Pharma Limited shares ?
The 52-week high and low of Parmax Pharma Limited share is ₹109.20 and ₹22.60 as of 24 Jul, 2026.
What is the market cap of Parmax Pharma Limited?
The market capitalisation of Parmax Pharma Limited is ₹39.25 Crores as on 24 Jul, 2026.
What are the stock symbols of Parmax Pharma Limited?
The stock symbol of Parmax Pharma Limited is 540359 on the BSE, and the ISIN is INE240T01014.
How to buy Parmax Pharma Limited shares?
To buy Parmax Pharma Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
What was yesterday's closing price for Parmax Pharma Limited shares ?
Parmax Pharma Limited shares closed yesterday at ₹104.92 on BSE
Can I buy Parmax Pharma Limited shares on Holidays?
No, shares of Parmax Pharma Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Parmax Pharma Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.